13F-HR filed by BOONE CAPITAL MANAGEMENT LLC
BOONE CAPITAL MANAGEMENT LLC filed this 13F-HR for the quarter ended 2026-03-31, filed 2026-05-15, with 13 holding rows worth $326,408,252.
- Accession
- 0001214659-26-006448
- Filer
- CIK 1882053
- Filed
- 2026-05-15
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q1 2026
A holdings report, 13 entries on the cover page, a total value of $326,408,252 stated on the cover page (in dollars after the unit check, H1), rows summing to $326,408,252 with VALUE read as dollars as filed, 13F file number 028-23055. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| MIRUM PHARMACEUTICALS INC | 604749101 | COM | 421,236 | $38,913,782 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 500,522 | $37,584,197 | dollars as filed | |
| Cigna Corporation | 125523100 | COM | 137,522 | $36,683,994 | dollars as filed | |
| Medtronic Plc | G5960L103 | COM | 398,065 | $34,492,332 | dollars as filed | |
| TELEFLEX INCORPORATED | 879369106 | COM | 278,792 | $33,346,311 | dollars as filed | |
| BIOMARIN PHARMACEUTICAL INC | 09061G101 | COM | 547,871 | $30,949,233 | dollars as filed | |
| GUARDIAN PHARMACY SVCS INC | 40145W101 | CL A | 631,193 | $23,770,728 | dollars as filed | |
| ASTRAZENECA PLC ORD | G0593M107 | ADR | 110,101 | $21,714,119 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 79,226 | $21,437,763 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 228,829 | $16,992,842 | dollars as filed | |
| AVANOS MED INC | 05350V106 | COM | 1,184,909 | $16,600,575 | dollars as filed | |
| KODIAK SCIENCES INC | 50015M109 | COM | 281,332 | $10,724,376 | dollars as filed | |
| TENAX THERAPEUTICS INC | 88032L605 | COM NEW | 200,000 | $3,198,000 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001214659-26-006448 | this filing | 2026-05-15 | acceptance time not in the bulk data set |